These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17119283)

  • 1. Mechanisms of aluminum-induced neurodegeneration in animals: Implications for Alzheimer's disease.
    Savory J; Herman MM; Ghribi O
    J Alzheimers Dis; 2006 Nov; 10(2-3):135-44. PubMed ID: 17119283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can studies of aluminum toxicity in vivo and in vitro provide relevant information on the pathogenesis and etiology of Alzheimer's disease?
    Savory J; Ghribi O
    J Alzheimers Dis; 2007 Jul; 11(4):429-30; discussion 431-2. PubMed ID: 17656820
    [No Abstract]   [Full Text] [Related]  

  • 4. Reversal by desferrioxamine of tau protein aggregates following two days of treatment in aluminum-induced neurofibrillary degeneration in rabbit: implications for clinical trials in Alzheimer's disease.
    Savory J; Huang Y; Wills MR; Herman MM
    Neurotoxicology; 1998 Apr; 19(2):209-14. PubMed ID: 9553957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging.
    Savory J; Rao JK; Huang Y; Letada PR; Herman MM
    Neurotoxicology; 1999 Oct; 20(5):805-17. PubMed ID: 10591516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aluminum induces tau aggregation in vitro but not in vivo.
    Mizoroki T; Meshitsuka S; Maeda S; Murayama M; Sahara N; Takashima A
    J Alzheimers Dis; 2007 Jul; 11(4):419-27. PubMed ID: 17656819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abeta(1-42) and aluminum induce stress in the endoplasmic reticulum in rabbit hippocampus, involving nuclear translocation of gadd 153 and NF-kappaB.
    Ghribi O; Herman MM; DeWitt DA; Forbes MS; Savory J
    Brain Res Mol Brain Res; 2001 Nov; 96(1-2):30-8. PubMed ID: 11731006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofibrillary lesions in experimental aluminum-induced encephalopathy and Alzheimer's disease share immunoreactivity for amyloid precursor protein, A beta, alpha 1-antichymotrypsin and ubiquitin-protein conjugates.
    Huang Y; Herman MM; Liu J; Katsetos CD; Wills MR; Savory J
    Brain Res; 1997 Oct; 771(2):213-20. PubMed ID: 9401741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can the controversy of the role of aluminum in Alzheimer's disease be resolved? What are the suggested approaches to this controversy and methodological issues to be considered?
    Savory J; Exley C; Forbes WF; Huang Y; Joshi JG; Kruck T; McLachlan DR; Wakayama I
    J Toxicol Environ Health; 1996 Aug; 48(6):615-35. PubMed ID: 8772802
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease and amyloid: culprit or coincidence?
    Skaper SD
    Int Rev Neurobiol; 2012; 102():277-316. PubMed ID: 22748834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GDNF protects against aluminum-induced apoptosis in rabbits by upregulating Bcl-2 and Bcl-XL and inhibiting mitochondrial Bax translocation.
    Ghribi O; Herman MM; Forbes MS; DeWitt DA; Savory J
    Neurobiol Dis; 2001 Oct; 8(5):764-73. PubMed ID: 11592846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein aggregation in Alzheimer's disease and other neoropathological disorders.
    Dimakopoulos AC
    Curr Alzheimer Res; 2005 Jan; 2(1):19-28. PubMed ID: 15977986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
    Terwel D; Dewachter I; Van Leuven F
    Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuro-amelioration of cinnamaldehyde in aluminum-induced Alzheimer's disease rat model.
    Mustafa HN
    J Histotechnol; 2020 Mar; 43(1):11-20. PubMed ID: 31460853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrillar beta-amyloid evokes oxidative damage in a transgenic mouse model of Alzheimer's disease.
    Matsuoka Y; Picciano M; La Francois J; Duff K
    Neuroscience; 2001; 104(3):609-13. PubMed ID: 11440793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogenesis of Alzheimer's disease and dementia.
    Bugiani O
    Rev Neurol (Paris); 1999; 155 Suppl 4():S28-32. PubMed ID: 10637935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association of aluminum Alzheimer's disease, and neurofibrillary tangles.
    Perl DP; Good PF
    J Neural Transm Suppl; 1987; 24():205-11. PubMed ID: 3316495
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An aluminum-based rat model for Alzheimer's disease exhibits oxidative damage, inhibition of PP2A activity, hyperphosphorylated tau, and granulovacuolar degeneration.
    Walton JR
    J Inorg Biochem; 2007 Sep; 101(9):1275-84. PubMed ID: 17662457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer morphology is not increased in dialysis-associated encephalopathy and long-term hemodialysis.
    Reusche E; Koch V; Lindner B; Harrison AP; Friedrich HJ
    Acta Neuropathol; 2001 Mar; 101(3):211-6. PubMed ID: 11307619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there any relationship between aluminum and Alzheimer's disease?
    Eichhorn GL
    Exp Gerontol; 1993; 28(4-5):493-8. PubMed ID: 8224045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.